This review examines Agada Yoga, the antidotal pharmaceutics of Agadtantra, as a distinct yet underexplored contribution of Ayurveda to toxicology and integrative medicine. Situated against rising burdens of environmental, occupational and iatrogenic toxic exposures, the paper reassesses classical formulations for their contemporary pharmacological and clinical relevance in managing Visha Rogas and toxin-related morbidities. The objectives are to consolidate conceptual foundations of Agada formulations, map their pharmacodynamic profiles, critically appraise preclinical and clinical evidence, and identify translational and regulatory pathways for their development.
Methodologically, the review follows a PRISMA-guided systematic search and narrative synthesis of 32 selected sources, combining classical-textual analysis with evaluation of experimental, clinical, phytopharmaceutical and policy literature. The paper is structured into six sections: introduction; systematic research methodology; classical foundations of Agada Yoga and Visha Rogas; classification, composition and pharmacognosy of major formulations; pharmacological, preclinical and clinical evidence; and an integrative discussion with future directions.
Findings indicate convergences between traditional descriptions of Vishaghna, D??? Visha and organ protection and modern evidence for antioxidant, anti-inflammatory, hepatoprotective, nephroprotective, myeloprotective and antivenom activities of selected Agadas. The review highlights both the therapeutic promise and the limitations of the current evidence base, particularly the paucity of robust clinical trials, standardised formulations and biomarker-integrated outcomes. It argues for a phased research agenda encompassing quality control, mechanistic studies, phytopharmaceutical development, nanotechnology-enhanced delivery and strengthened pharmacovigilance. Collectively, the review positions Agada Yoga as a credible platform for future antidotal and organ-protective interventions within evidence-based integrative toxicology.